Literature DB >> 7276828

In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon.

P Casali, J G Sissons, M J Buchmeier, M B Oldstone.   

Abstract

Purified hemagglutinin and fusion glycoproteins of measles virus either in soluble form or inserted in artifical membranes bind to human peripheral blood lymphocytes and induce cell-mediated cytotoxicity (CMC) in a dose-response fashion. Both autologous and heterologous noninfected target cells are lysed in vitro. The expression of CMC is not inhibited by anti-measles virus antibody added to lymphocytes previously exposed to viral glycoproteins. THe killer lymphocytes are Fc receptor positive, both erythrocyte-rosetting and non-erythrocyte-rosetting, as assessed by both positive and negative selection experiments. The induction of nonspecific CMC by viral glycoproteins either in the soluble state or inserted into artificial membranes could be segregated from the CMC associated with whole virions. First, on kinetics studies, purified viral glycoproteins induced CMC more rapidly than did whole virus. Second, viral glycoprotein-produced response occurred in the absence of detectable release of interferon into the culture medium, whereas CMC activity due to whole virions was associated with interferon release. The fact that purified measles virus glycoproteins integrated into artificial membrane bilayers were as efficient as their soluble counterparts in inducing CMC suggests that the hydrophobic portion of the glycoproteins was not involved in the induction and expression of the lytic activity. Purified glycoproteins from lymphocytic choriomeningitis virus behave similarly, although this virus is unrelated to measles virus. It is inferred that interferon-independent CMC induced by viral glycoproteins might account for some of the biological reactions occurring early in the control of a viral infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276828      PMCID: PMC2186447          DOI: 10.1084/jem.154.3.840

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin.

Authors:  M B Oldstone
Journal:  Prog Med Virol       Date:  1975

2.  C3-reacted sepharose: a preparative method for separating T and B lymphocytes.

Authors:  P Casali; B M Perussia
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

3.  A micro assay for mouse and human interferon. II. Dose-response in different in cell-virus systems.

Authors:  H Dahl
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-06

4.  Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.

Authors:  G Trinchieri; M De Marchi; W Mayr; M Savi; R Ceppellini
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  On the varied biologic effects of interferon.

Authors:  I Gresser
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

7.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes.

Authors:  L H Perrin; A Tishon; M B Oldstone
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.

Authors:  L H Perrin; B S Joseph; N R Cooper; M B Oldstone
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  18 in total

1.  Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells.

Authors:  I Kurane; D Hebblewaite; F A Ennis
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

2.  Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.

Authors:  A L Cunningham; J R Noble
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 3.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 4.  Natural killer cells in resistance to virus-infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins.

Authors:  D J Arora; M Houde; D M Justewicz; R Mandeville
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection.

Authors:  T F Abidi; T D Flanagan
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Tumorigenicity of persistently infected tumors in nude mice is a function of both virus and host cell type.

Authors:  S B VandePol; J J Holland
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Activation and role of natural killer cells in virus infections.

Authors:  C A Biron; R M Welsh
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

9.  Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.

Authors:  D Shouval; B Rager-Zisman; P Quan; D A Shafritz; B R Bloom; L M Reid
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein.

Authors:  S A Ali; R C Rees; J Oxford
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.